| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBOGESIC 32 mg/ml+9,6 mg/ml | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | SUSP. ORALA | N02BE51 | W69595002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W68305001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W68305002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W68306001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W68306002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W67224002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69238001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 dispersie injectabila | TOZINAMERAN/FAMTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69195001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 dispersie injectabila | TOZINAMERAN/FAMTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69195002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543001 | ORION CORPORATION - FINLANDA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543002 | ORION CORPORATION - FINLANDA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543003 | ORION CORPORATION - FINLANDA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman